期刊文献+

湘A1号、2号对免疫缺陷动物免疫保护作用的研究 被引量:9

The Researches of Immune Protection Effects of Xiang A NO 1,Xiang A NO 2 on the Immunodeficiency Animal
下载PDF
导出
摘要 目的:探讨湘A 1号、2号对免疫缺陷动物的免疫保护作用。方法:通过小鼠腹腔注射环孢菌素A建立免疫缺陷动物模型,观察湘A1号、2号对免疫缺陷动物模型胸腺重量指数、肺重量指数、肝脏重量指数、腹腔巨噬细胞吞噬功能以及胸腺、脾脏、肺和小肠组织的病理变化的影响。结果:与模型对照组比较,湘A1号的低、中、高剂量组及湘A2号中、高剂量组可显著提高胸腺重量指数(P<0.01或P<0.05),湘A1号高剂量组、湘A2号中、高剂量组能显著降低肺重量指数(P<0.01),湘A1号和A2号的低、中、高剂量组均可显著降低肝重量指数(P<0.01或P<0.05);湘A1号、湘A2号低、中、高剂量组能显著提高腹腔巨噬细胞吞噬百分率(P<0.01),湘A1号中、高剂量及湘A2号低、中、高剂量组能显著提高腹腔巨噬细胞的吞噬指数(P<0.01或P<0.05);湘A1号高剂量及湘A2号中剂量能明显减轻胸腺组织萎缩、局部脂肪变性,肺泡壁增厚,小肠上皮脱落等病理变化。结论:湘A1号、2号对环孢菌素A所致的免疫缺陷动物模型有一定的免疫保护作用。 Objective: To investigate the immune protection effect of Xiang A NO 1 and Xiang A NO 2 on the immunodeficiency animal.Methods: The immunodeficiency mice model is established by intraperitoneal injection of cyclosporine A.To observe the effects of Xiang A NO 1 and Xiang A NO 2 on thymus weight index,lung weight index,liver mass index,abdominal macrophage function as well as the pathological changes of the thymus,lungs,liver and the small intestine of Immunodeficiency mice.Results: Compared with the model group,The low-dose group,middle-dose group,high-dose group of Xiang A NO1and the middle-dose group,high-dose group of Xiang A NO 2 could significantly enhance the immune organs thymus mass index(P0.01 or P0.05);The high-dose group of Xiang A NO1 and the middle-dose group,high-dose group of Xiang A NO 2 could significantly reduce lung weight index(P0.01);The low-dose group,middle-dose group,high-dose group of Xiang A NO1 and Xiang A NO 2 could significantly reduce liver mass index(P0.01 or P0.05);The low-dose group,middle-dose group,high-dose group of Xiang A NO1 and Xiang A NO 2 could significantly enhance the phagocytic percentage of peritoneal macrophages(P0.01);The middle-dose group,high-dose group of Xiang A NO1 and the low-dose group,middle-dose group,high-dose group of Xiang A NO 2 could significantly enhance the phagocytic index of peritoneal macrophages(P0.01 or P0.05);The high-dore group of Xiang NO1 and the middle-dnse group of Xiang A NO 2 bould rignificantlx reduce qatholngical changes of thd thxmts atrnphy,partial fatty degeneration,alveolar wall thickening and Intestinal epithelial shedding.Conclusion: Xiang A NO1 and Xiang A NO2 play Immune protection On immunodeficiency mice model established by intraperitoneal injection of cyclosporine A.
出处 《中华中医药学刊》 CAS 2011年第4期828-831,共4页 Chinese Archives of Traditional Chinese Medicine
基金 湖南省科技厅科技计划重点项目(2010FJ2007) 湖南省卫生厅中医药科研基金重大课题(6201)
关键词 湘A1号 湘A2号 环孢菌素A 免疫 Xiang A NO 1 Xiang A NO 2 cyclosporine A immune
  • 相关文献

参考文献5

二级参考文献35

共引文献30

同被引文献73

  • 1尹明星,曹艳,施春阳,王文清,方建国.中药防治细胞因子风暴的研究进展[J].中草药,2020,51(5):1089-1095. 被引量:68
  • 2黄继汉,黄晓晖,陈志扬,郑青山,孙瑞元.药理试验中动物间和动物与人体间的等效剂量换算[J].中国临床药理学与治疗学,2004,9(9):1069-1072. 被引量:1283
  • 3Clouer C L, Holtz C M,Mullett M,et al.Activity of a novel combinedantiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1.Antimicrobial Agents and Chemotherapy,2012, 56(4):29.
  • 4Jeandet P’Bessis R’Maume B,et al.Effect of enological practices on the res.veractrol isomer content of wine.Agric food Chem,1995,43(2):316.
  • 5Sharnia S,Chopra K,Kulkami S K,et al.Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 C0-stimulatory pathway.Clin Exp Immunol,2007,147(1): 155-163.
  • 6Meishiang Jang,Lining Cai,George 0 Udeani,et al.Cancer chemoprewentive activity of resveratrol,a natural product derived from grapes.Science,1997,275(10):218-220.
  • 7Carre N’Boufassa F,Hubert J B,et al.Predictive value of viral load and other markers for progression to clinical AIDS after CD4 cell count falls below 200/microl.Intemation Journal of Epidemiology, 1998,27:897-903.
  • 8XU Wei-long,YANG Ji-bing.2012,Latest Researches on Acquired Immunodeficiency Syndromewith Tradition Chinese Medicine. Medical Recapitulate,2012,18(3):2102-2104.
  • 9Chen S, Lai C, Wu X, et al. Variability of bio-clin- ical parameters in Chinese-origin Rhesus ma- caques infected with simian immunodeficiency vi- rus: a nonhuman primate AIDS model [ J ]. PLoS One, 2011,6(8): E23177.
  • 10Institute of Laboratory Animal Resources, Com- mission on Life Sciences, National Research Council. Guide for the care and use of laboratory animals [ M ]. Washington DC: National Academy of Sciences, 2011 : 35.

引证文献9

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部